Every Medical Research story tagged primary.
Bristol Myers Squibb's Phase 3 trial of admilparant for idiopathic pulmonary fibrosis met its primary endpoint only at the lower 60 mg dose, raising questions about dose response despite a positive safety profile.
ArriVent BioPharma's oral lung cancer drug furmonertinib failed to significantly delay tumor progression versus chemotherapy in a late-stage study, missing its primary endpoint despite a modest numerical benefit and triggering a sharp drop in the company's share price.
Amgen's experimental drug dazodalibep met its primary goal in a Phase 3 study for Sjögren's syndrome, showing early and sustained symptom improvement.
AbbVie reported that its bispecific antibody etentamig met the primary endpoint in a Phase 3 trial for multiple myeloma.